Home Delivery of DASH Diet Groceries Achieves Medication-Level Reductions in Blood Pressure for High-Risk Black Adults
ACC.26 study shows home-delivered DASH groceries and dietitian counseling reduce systolic blood pressure by 7 mm Hg in Black adults living in food deserts.
By: AXL Media
Published: Mar 30, 2026, 4:18 AM EDT
Source: Information for this report was sourced from American College of Cardiology

Bridging the Health Equity Gap Through Nutritional Access
Shutterstock
A new clinical intervention is proving that the path to heart health may be found in the grocery aisle rather than the pharmacy. According to Stephen Juraschek, an associate professor at Harvard Medical School, providing Black adults with direct access to DASH-compliant foods leads to blood pressure reductions comparable to standard medications. The study focused specifically on individuals living in "food deserts"—urban areas with limited access to fresh, high-quality produce. By removing the logistical and financial barriers to a healthy diet, researchers observed a significant shift in cardiovascular markers, providing a scalable model for self-managing hypertension in underserved communities.
Addressing Disparities in Hypertension and Food Security
The study highlights a critical public health crisis: in the United States, 58% of Black adults live with hypertension, compared to 48% of the general adult population. This disparity often leads to higher rates of stroke and heart disease. For the 176 participants in this trial, standard medical advice was bolstered by tangible resources. While half of the group received only a stipend and a pamphlet, the intervention group received home-delivered groceries tailored to their preferences but rooted in DASH principles—high in potassium, low in sodium, and restricted in saturated fats. This approach allowed families to maintain their cultural food preferences while meeting clinical health goals.
Quantifying the Impact of Dietitian-Guided Grocery Delivery
Categories
Topics
Related Coverage
- Bi-Annual Hypertension Injections Could Revolutionize Care While Sparking Warnings Against Physician and Patient Moral Hazard
- Phase 2 Trial of Investigational Hypertension Injection Tonlamarsen Reveals Persistent Protein Suppression but Conflicting Blood Pressure Data
- UTEP Clinical Trial Demonstrates Six Weeks of Boxing Training Outperforms Medication in Reducing Hypertension for Young Adults
- Routine Arterial Stiffness Metrics Emerged As Critical Predictors For Long Term Dementia Risk In Major Clinical Analysis